Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Nhau dzeKambani

Kurapa kweBioOCUS Medical Group Dual CD19/BCMA CAR-T Kunopa Mhedzisiro Inofadza muRefractory Myasthenia Gravis: Rwendo rweMurwere Mudiki

Kurapa kweBioOCUS Medical Group Dual CD19/BCMA CAR-T Kunopa Mhedzisiro Inofadza muRefractory Myasthenia Gravis: Rwendo rweMurwere Mudiki

2026-04-24
Myasthenia Gravis (MG) chirwere chisingaperi che autoimmune neuromuscular disorder chinokonzerwa nema autoantibodies (kunyanya anti-acetylcholine receptor antibodies, AchRAb) ayo anokanganisa kutaurirana kwetsinga netsandanyama, zvichikonzera kushanduka-shanduka kwekushaya simba, ptosis, dysphagia, uye muzvikamu zvikuru zve ...
tarisa ruzivo
Kubudirira Muzvidzidzo | Chikwata Chekurapa chaLu Daopei Chaburitsa Chidzidzo Chekiriniki Chinoshamisa muBritish Journal of Haematology

Kubudirira Muzvidzidzo | Chikwata Chekurapa chaLu Daopei Chaburitsa Chidzidzo Chekiriniki Chinoshamisa muBritish Journal of Haematology

2024-12-23

Chikwata cheLu Daopei Medical Team, chinotungamirwa naDr. Cao Xingyu naProf. Lu Peihua, chakaburitsa bepa rekutsvaga rekiriniki rakakosha mu Chinyorwa cheBritish cheHematology (Impact Factor 5.1). Chidzidzo ichi chinoongorora kuchengetedzeka uye kushanda kwe allogeneic hematopoietic hematopoietic stem cell transplantation (allo-HSCT) mushure me autologous CD7 CAR-T therapy ye refractory uye recurred T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (R/R T-ALL/T-LBL).

tarisa ruzivo
Ongororo yeMulti-Center Inoratidza Kufungidzira Kwakanaka Kwevarwere VeHematologic Malignancy Vari Kuiswa MuMMUD Allogeneic Stem Cell Transplant neATG

Ongororo yeMulti-Center Inoratidza Kufungidzira Kwakanaka Kwevarwere VeHematologic Malignancy Vari Kuiswa MuMMUD Allogeneic Stem Cell Transplant neATG

2024-11-2020

Ongororo huru yezvipatara zvakawanda muChina inoratidza mhedzisiro yakanaka kune varwere vane chirwere cheropa chinouraya vari kuisirwa masero emuviri asina kuenzana (MMUD) neATG yekudzivirira GVHD.

tarisa ruzivo
Nyaya yeMurwere: B-ALL ine Njodzi Yakanyanya, Kuisirwa Bone Morrow paMwedzi Mipfumbamwe, Makore maviri gare gare—Kutanga Kwakanaka kweMurwi Wechidiki

Nyaya yeMurwere: B-ALL ine Njodzi Yakanyanya, Kuisirwa Bone Morrow paMwedzi Mipfumbamwe, Makore maviri gare gare—Kutanga Kwakanaka kweMurwi Wechidiki

2024-11-19

Mwana ane mwedzi mipfumbamwe, akaonekwa aine Acute B Lymphoblastic Leukemia (B-ALL) ine njodzi huru, akavhiyiwa mapfupa. Makore maviri gare gare, mwana wacho ari kukura zvakanaka uye agadzirira kuenda kukireshi.

tarisa ruzivo
Kunzwisisa Thalassemia: Gwaro Rakazara reAlfa neBeta Forms

Kunzwisisa Thalassemia: Gwaro Rakazara reAlfa neBeta Forms

2024-11-07

Thalassemia chirwere chinopfuura chimwe chete. Gwaro iri rinoongorora alpha ne beta thalassemia, zvikonzero zvayo, zviratidzo, uye nzira dzekurapa dziripo paBIOOCUS International Medical Center.

tarisa ruzivo
Dr. Lu Peihua Vanoratidza Kubudirira Mukurapa kweCAR-T paMusangano weGore we29 weAPBMT

Dr. Lu Peihua Vanoratidza Kubudirira Mukurapa kweCAR-T paMusangano weGore we29 weAPBMT

2024-10-21

Pamusangano wegore negore wechi29 weAsia-Pacific Blood and Marrow Transplantation (APBMT), Dr. Lu Peihua vakapa hurukuro huru pamusoro pekubudirira kweCAR-T cell therapy muChina. Ruzivo rwechokwadi rwechikwata chavo kubva kukiriniki rwakagamuchirwa pasi rose, vachiratidza mipiro yavo mukurapa gomarara reropa.

tarisa ruzivo
ASH 2024: Chikwata cheLu Daopei Chinoratidza Zviitiko gumi nezvitatu zveKutsvagurudza muHematology

ASH 2024: Chikwata cheLu Daopei Chinoratidza Zviitiko gumi nezvitatu zveKutsvagurudza muHematology

2024-10-08

Pamusangano weASH 2024 uri kuuya, timu yekurapa yeLu Daopei Hospital icharatidza zvakawanikwa zvitsvakurudzo gumi nezvitatu zvitsvakurudzo, zvichiratidza kufambira mberi mukurapa kweropa uye mukana wekurapa kweCAR-T, vachisimbisazve kuzvipira kwavo mukuvandudza mhedzisiro yevarwere.

tarisa ruzivo
Kukunda Lymphoma neDual CAR-T Therapy

Kukunda Lymphoma neDual CAR-T Therapy

2024-09-27

Mushure mekurwara nechirwere chelymphoma kwemakore matatu, mukadzi ane makore makumi matanhatu nerimwe ekuberekwa akawana zororo rakazara kuburikidza nekurapa kweCAR-T kaviri paBIOOCUS, zvichiratidza mukana wekurapa kenza nenzira yepamusoro kuchinja hupenyu.

tarisa ruzivo
Bioocus Inobatanidzwa muIGC 2024 kuti Iongorore Kubatana Kutsva uye MaModheru Ebhizinesi muImmuno-Gene uye Cell Therapy

Bioocus Inobatanidzwa muIGC 2024 kuti Iongorore Kubatana Kutsva uye MaModheru Ebhizinesi muImmuno-Gene uye Cell Therapy

2024-09-11

Bioocus inofara kupinda mumusangano wechisere weImmuno-Gene and Cell Therapy Congress (IGC 2024)! Tinotarisira kushanda pamwe chete nenyanzvi dzepasi rose uye kutsvaga mabhizinesi matsva anoenderana netekinoroji yekurapa majini nemasero. Pamwe chete, ngatigadzirei ramangwana rekurapa immunotherapy.

tarisa ruzivo
Kushanda Kwakanyanya kweCD7 CAR-T Therapy yeB-Cell Malignancies: Kubudirira Mukurapa Kenza

Kushanda Kwakanyanya kweCD7 CAR-T Therapy yeB-Cell Malignancies: Kubudirira Mukurapa Kenza

2024-09-06

Ongororo yazvino inoratidza kushanda uye kuchengetedzeka kweCD7 CAR-T cell therapy mukurapa B-cell acute lymphoblastic leukemia (B-ALL) yakadzoka kana kuti isingadzoreki uye T-cell lymphoblastic lymphoma (T-LBL). Chidzidzo ichi chakaitwa neBIOOCUS pamwe chete neLu Daopei Hospital, chinoratidza mhedzisiro inovimbisa kuvarwere, ichipa imwe nzira ine simba pane chemotherapy yechinyakare.

tarisa ruzivo
Kushanda Kwenguva Refu KweCD19 CAR T-Cell Therapy Mukurapa Relapsed/Refractory Acute Lymphoblastic Leukemia

Kushanda Kwenguva Refu KweCD19 CAR T-Cell Therapy Mukurapa Relapsed/Refractory Acute Lymphoblastic Leukemia

2024-08-27

Ongororo itsva inoratidza kubudirira kwenguva refu kwekurapa kweCD19 CAR T-cell mukurapa varwere vane relapse/refractory acute lymphoblastic leukemia (ALL) mushure mekuisirwa allogeneic hematopoietic stem cell transplantation, zvichipa tariro itsva mu hematology.

tarisa ruzivo
Bioocus Inofambira Mberi Mukurapa Vana Vane Acute Lymphoblastic Leukemia

Bioocus Inofambira Mberi Mukurapa Vana Vane Acute Lymphoblastic Leukemia

2024-08-19

Bioocus iri pamberi mukugadzira mishonga yeCAR-T yechizvarwa chinotevera. Chinyorwa chitsva chaDr. Chunrong Tong nechikwata chake kuLu Daopei Hospital chinoratidza kufambira mberi kwakakosha nematambudziko mukushandiswa kwemishonga yeCD19 CAR-T yechizvarwa chechipiri muvarwere vevana, zvichiratidza kuzvipira kwaBioocus mukurapa kenza nenzira itsva.

tarisa ruzivo